Miskawaan Health Group and Jiuzhang Biotech Announced New Cooperation to Bring the Next Generation Cancer and Anti-aging Therapies to Thailand
The cooperation focuses on patented CHA products of Jiuzhang Biotech.
Miskawaan Health Group has obtained the import and distribution rights for these products in Thailand.
The initial focus will be a cancer and anti-aging cancer and anti-aging therapy at Miskawaan Health Group in Bangkok and Koh Samui.
On September 7, 2024, Miskawaan Health Group (hereinafter referred to as “Miskawaan Health Group”) signed an exclusive cooperation agreement with the senior management of Sichuan Jiuzhang Biological Science and Technology Co., Ltd. (herein after referred to as “Jiuzhang Biotech”), authorizing Miskawaan Health Group to import, distribute and use the patented CHA products of Jiuzhang Biotech in Thailand.
CHA is a natural active ingredient derived from plants, which has effects of strengthening the human immune system and preventing disease and aging. It is also widely used to fight against chronic diseases such as cancers, effectively treating cancer cells by boosting the immune system with minimal side effects.
The patented CHA products of Jiuzhang Biotech, administered by injection, has successfully completed Phase I and Phase II clinical trials in China against brain cancer, with very good outcomes.
“The products of Jiuzhang Biotech have revolutionized the field of anti-aging and certain cancer treatments. Miskawaan Health Group is very pleased to partner with Jiuzhang Biotech to provide these next-generation products to our patients. The products of Jiuzhang Biotech are derived from plant extracts, which are in perfect fit with the natural health strategy of Miskawaan Health Group”, said David Boehm, Chairman and CEO of Miskawaan Health Group.
“It is the first time that Jiuzhang Biotech has reached a distribution agreement with a foreign partner. We visited all three branches of Miskawaan Health Group in Thailand and were deeply impressed with the forward-thinking medical care provided by their physicians and healthcare teams. We believe that this cooperation agreement will lay the foundation for closer cooperation between Jiuzhang Biotech and Miskawaan Health Group”, said Zhang Jie, Chairman and CEO of Jiuzhang Biotech.
About Miskawaan Health Group (www.miskawaanhealth.com):
Miskawaan Health Group has set up two branches in Bangkok and one in Koh Samui. These branches provide quality medical services to local and international clients, focusing on anti-aging and anti-cancer treatments. The doctors, scientists and medical team in Miskawaan is willing to tailor effective treatment regimens to patients and use advanced diagnostic techniques to combine natural remedies with traditional medicine to achieve the optimal therapeutic effect.
Miskawaan Health Group was founded in 2018 by David Boehm, Chairman and CEO, and Dr. Johannes Wessolly, Medical Director. It has three health centers, which are located at the Miskawaan International Hospital under construction in Bangkok, Miskawaan Anti-Aging Clinic at the Sukhothai Bangkok, and a rehabilitation clinic at Miskawaan Villa on Koh Samui Island.